{{item.videoDuration}}
{{item.title}}
{{item.text}}
{{item.videoDuration}}
{{item.text}}
PwC Switzerland is pleased to announce that we have supported Galderma on its announced acquisition of ZO Skin Health, subject to regulatory approvals and other customary closing conditions.
PwC supported Galderma as an advisor on:
- Financial and Accounting Due Diligence;
- Tax Due Diligence;
- Value Creation; and
- IT Due Diligence
- Financial and Tax SPA support
The acquisition brings together two highly complementary, science-backed skincare brands and expands Galderma’s Dermatological Skincare portfolio in the attractive, fast-growing physician-dispensed skincare segment.
Congratulations to the Galderma team for this strategic acquisition.
The PwC team
Financial Due Diligence: Luca Borrelli (Partner), Nicola Barusco (Director), Aurelien Mauro (Senior Manager), Yali Xu (Senior Associate), Matteo Masini (Senior Associate), Yasin Uzun (Senior Associate)
Accounting Matters: Yazen Jamjum (Partner), Stefan Kilchhofer (Director), Pooja Sannidhi Hariharan (Senior Manager), Enrico Bogino (Manager)
Tax Due Diligence: Jürg Niederbacher (Partner, PwC Switzerland), Gabriel Neukomm (Partner, PwC Switzerland), Michalis Louca (Director, PwC Switzerland), Angus Greer (Manager, PwC Switzerland), Michelle Huber (Manager, PwC Switzerland), Yvett Tian (Senior Associate, PwC Switzerland), Nadja Krupciakova (Associate, PwC Switzerland), Olivia Graf (Associate, PwC Switzerland), Mirt Zwitter-Tehovnik (Partner, PwC US)
IT Due Diligence: Claude Fuhrer (Partner), Ali Quenahat (Senior Manager)
Integration & Value Creation: Alix Ekus (Director), Emma Decker (Manager)